ArticleBiomedicines2022

Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96.

Christina Boch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.